Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Savale (Le Kremlin Bicêtre, France), S. Akagi (Le Plessis Robinson, France), L. Tu (Le Plessis Robinson, France), R. Thuillet (Le Plessis Robinson, France), J. Bordenave (Le Plessis Robinson, France), T. Quatremare (Le Plessis Robinson, France), A. Cumont (Le Plessis Robinson, France), C. Phan (Le Plessis Robinson, France), A. Huertas (Le Plessis Robinson, France), M. Humbert (Le Kremlin Bicêtre, France), Y. Tamura (Le Kremlin Bicêtre, France), C. Guignabert (Le Kremlin Bicêtre, France). Uric acid contributes to the progression of pulmonary hypertension in rodents and humans. 3935

Member's Comments

No comment yet.

Related content which might interest you: A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Serum and pulmonary uric acid in pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2000332; 10.1183/13993003.00332-2020 Year: 2021 Uric acid, oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006 Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 1024-1029 Year: 2008 Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2015; 46: 431-443 Year: 2015 Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension Source: Eur Respir J, 53 (6) 1801524; 10.1183/13993003.01524-2018 Year: 2019 Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease? Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 1504-1512 Year: 2008 Hyaluronic acid is significantly increased in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006 R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models Source: Eur Respir J, 57 (5) 2003271; 10.1183/13993003.03271-2020 Year: 2021 Macitentan reduces progression of TGF-ß1-induced pulmonary fibrosis and pulmonary hypertension Source: Eur Respir J, 52 (2) 1701857; 10.1183/13993003.01857-2017 Year: 2018 How to detect disease progression in pulmonary arterial hypertension Source: Eur Respir Rev 2012; 21: 40-47 Year: 2012 How does inflammation contribute to pulmonary hypertension? Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017 Year: 2018 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Can retinoic acid protect the development of pulmonary emphysema induced by cigarette smoke in rats? Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006